Amount Raised
$11 Million
Round Type
Debt Financing
WilmingtonBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharmaDescription
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals" or the "Company"), a clinical-stage CNS biopharmaceutical company, today announced that it has obtained approximately $11 million in unsecured debt financing (the "Note") from Streeterville Capital, LLC, a Utah limited liability company. The Company intends to use the net proceeds from the Note (approximately $10 million) to support its NRX-101 development programs for the treatment of suicidal bipolar depression and PTSD and for general corporate purposes.
Quick answer
NRx Pharmaceuticals raised $11 Million in a Debt Financing round, dated November 7, 2022. NRx Pharmaceuticals is based in Wilmington, Delaware, United States.
- How much did NRx Pharmaceuticals raise?
- NRx Pharmaceuticals raised $11 Million in a Debt Financing round on November 7, 2022.
- What does NRx Pharmaceuticals do?
- NRx Pharmaceuticals, Inc. draws upon decades of collective, scientific, and drug-development experience to address very high unmet needs of patients.
- Where is NRx Pharmaceuticals based and how big is it?
- NRx Pharmaceuticals is based in Wilmington, Delaware, United States. Fundz records about 21 employees.
- Who are the decision-makers at NRx Pharmaceuticals?
- Fundz holds 3 contacts at NRx Pharmaceuticals, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as NRx Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Os Therapies raised $2M on November 16, 2022.
- Renibus Therapeutics raised $33M (Funding Round) on November 14, 2022.
- Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
Who to call at NRx Pharmaceuticals, and when
A new round usually means NRx Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NRx Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NRx Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NRx Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NRx Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NRx Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.